Tislelizumab and Pentostatin therapy reverse aggressive T-LGLL with near tetraploid karyotype
-
-
REFERENCES
[1] Alaggio R., Amador C., Anagnostopoulos I., et al. (2022). The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720−1748. DOI:10.1038/s41375-022-01620-2 [2] Arber D.A., Orazi A., Hasserjian R.P., et al. (2022). International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data. Blood 140:1200−1228. DOI:10.1182/blood.2022015850 [3] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). T-Cell Lymphomas. Version 2.2025. https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf. [4] Belhadj M., Mansour D., Kaltenbach S., et al. (2019). T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: A report of two cases with molecular characterization. Haematologica 104:e117−e120. DOI:10.3324/haematol.2018.205542 [5] Olteanu H., Harrington A.M., Ramirez S., et al. (2010). Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. Br. J. Haematol. 150:480−481. DOI:10.1111/j.1365-2141.2010.08218.x [6] Zhang L., Ramchandren R., Papenhausen P., et al. (2014). Transformed aggressive γδ-variant T-cell large granular lymphocytic leukemia with acquired copy neutral loss of heterozygosity at 17q11.2q25.3 and additional aberrations. Eur. J. Haematol. 93:260-264. DOI:10.1111/ejh.12313 [7] Avenarius M., Abrams Z., Guo L., et al. (2025). Novel recurrent cytogenetic abnormalities predict overall survival in tetraploid/near-tetraploid myelodysplastic syndrome and acute myeloid leukemia. Cancers (Basel) 17:1277. DOI:10.3390/cancers17081277 [8] Miller C.R., Ruppert A.S., Heerema N.A., et al. (2017). Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib. Blood Adv. 1:1584−1588. DOI:10.1182/bloodadvances.2017007302 [9] Fang J., Shankar N., Bao L., et al. (2024). Near-tetraploidy/tetraploidy acute myeloid leukemia with clinical, pathologic and molecular characteristics. Leuk. Lymphoma 65:1820−1829. DOI:10.1080/10428194.2024.2382923 [10] Martinović K.M., Vuletić A., Miletić N.T., et al. (2025). Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients. Clin. Immunol. 280:110557. DOI:10.1016/j.clim.2025.110557 -
ABOUT THIS ARTICLE
Cite this article:
Cai Y. and Tang L. (2026). Tislelizumab and Pentostatin therapy reverse aggressive T-LGLL with near tetraploid karyotype. The Innovation Medicine 4:100202. https://doi.org/10.59717/j.xinn-med.2026.100202
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Cai Y. and Tang L. (2026). Tislelizumab and Pentostatin therapy reverse aggressive T-LGLL with near tetraploid karyotype. The Innovation Medicine 4:100202. https://doi.org/10.59717/j.xinn-med.2026.100202
Format
Content
DownLoad:
-
Figure 1.
Clinical and cytogenetic evolution of T-LGLL throughout treatment
